UK Markets close in 8 hrs 30 mins

Vistin Pharma ASA: Invitation to Q3 2020 conference call

Vistin Pharma ASA
·1-min read

Oslo, Norway, 26 October 2020

Vistin Pharma ASA will release its third quarter 2020 results on Friday 30 October 2020. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 30 October at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in Norwegian.

The third quarter conference call will be available via web and audio through the following access points:

Telephone conference:

Dial in details, Participants:
Confirmation Code:........ 9184755
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167


Webcast:
https://edge.media-server.com/mmc/p/r4qc96ix

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com


About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.